BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26744410)

  • 1. Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosis.
    Evans IC; Barnes JL; Garner IM; Pearce DR; Maher TM; Shiwen X; Renzoni EA; Wells AU; Denton CP; Laurent GJ; Abraham DJ; McAnulty RJ
    Clin Sci (Lond); 2016 Apr; 130(8):575-86. PubMed ID: 26744410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotype.
    Robinson CM; Neary R; Levendale A; Watson CJ; Baugh JA
    Respir Res; 2012 Aug; 13(1):74. PubMed ID: 22938014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice.
    Huang SK; Fisher AS; Scruggs AM; White ES; Hogaboam CM; Richardson BC; Peters-Golden M
    Am J Pathol; 2010 Nov; 177(5):2245-55. PubMed ID: 20889571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis.
    Sanders YY; Pardo A; Selman M; Nuovo GJ; Tollefsbol TO; Siegal GP; Hagood JS
    Am J Respir Cell Mol Biol; 2008 Nov; 39(5):610-8. PubMed ID: 18556592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis.
    Coward WR; Feghali-Bostwick CA; Jenkins G; Knox AJ; Pang L
    FASEB J; 2014 Jul; 28(7):3183-96. PubMed ID: 24652950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
    Wang Y; Fan PS; Kahaleh B
    Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β1 epigenetically modifies Thy-1 expression in primary lung fibroblasts.
    Neveu WA; Mills ST; Staitieh BS; Sueblinvong V
    Am J Physiol Cell Physiol; 2015 Nov; 309(9):C616-26. PubMed ID: 26333597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts.
    Sanders YY; Tollefsbol TO; Varisco BM; Hagood JS
    Am J Respir Cell Mol Biol; 2011 Jul; 45(1):16-23. PubMed ID: 20724553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice.
    Keerthisingam CB; Jenkins RG; Harrison NK; Hernandez-Rodriguez NA; Booth H; Laurent GJ; Hart SL; Foster ML; McAnulty RJ
    Am J Pathol; 2001 Apr; 158(4):1411-22. PubMed ID: 11290559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis.
    Dees C; Schlottmann I; Funke R; Distler A; Palumbo-Zerr K; Zerr P; Lin NY; Beyer C; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2014 Jun; 73(6):1232-9. PubMed ID: 23698475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.
    Horswill MA; Narayan M; Warejcka DJ; Cirillo LA; Twining SS
    Exp Eye Res; 2008 Apr; 86(4):586-600. PubMed ID: 18291368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis.
    Coward WR; Watts K; Feghali-Bostwick CA; Knox A; Pang L
    Mol Cell Biol; 2009 Aug; 29(15):4325-39. PubMed ID: 19487460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.
    Gabasa M; Royo D; Molina-Molina M; Roca-Ferrer J; Pujols L; Picado C; Xaubet A; Pereda J
    PLoS One; 2013; 8(6):e65445. PubMed ID: 23755232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Regulation of Caveolin-1 Gene Expression in Lung Fibroblasts.
    Sanders YY; Liu H; Scruggs AM; Duncan SR; Huang SK; Thannickal VJ
    Am J Respir Cell Mol Biol; 2017 Jan; 56(1):50-61. PubMed ID: 27560128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suberanilohydroxamic acid prevents TGF-β1-induced COX-2 repression in human lung fibroblasts post-transcriptionally by TIA-1 downregulation.
    Pasini A; Brand OJ; Jenkins G; Knox AJ; Pang L
    Biochim Biophys Acta Gene Regul Mech; 2018 May; 1861(5):463-472. PubMed ID: 29555582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation of cyclooxygenase-2 gene in esophageal squamous cell carcinoma.
    Meng XY; Zhu ST; Zong Y; Wang YJ; Li P; Zhang ST
    Dis Esophagus; 2011 Aug; 24(6):444-9. PubMed ID: 21166741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between EZH2 and G9a Regulates CXCL10 Gene Repression in Idiopathic Pulmonary Fibrosis.
    Coward WR; Brand OJ; Pasini A; Jenkins G; Knox AJ; Pang L
    Am J Respir Cell Mol Biol; 2018 Apr; 58(4):449-460. PubMed ID: 29053336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NF-κB family member RelB regulates microRNA miR-146a to suppress cigarette smoke-induced COX-2 protein expression in lung fibroblasts.
    Zago M; Rico de Souza A; Hecht E; Rousseau S; Hamid Q; Eidelman DH; Baglole CJ
    Toxicol Lett; 2014 Apr; 226(2):107-16. PubMed ID: 24472607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease.
    Cahill KN; Raby BA; Zhou X; Guo F; Thibault D; Baccarelli A; Byun HM; Bhattacharyya N; Steinke JW; Boyce JA; Laidlaw TM
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):34-40. PubMed ID: 26051534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis.
    Watson CJ; Horgan S; Neary R; Glezeva N; Tea I; Corrigan N; McDonald K; Ledwidge M; Baugh J
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):127-37. PubMed ID: 26130616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.